Back to search

Article

Base-edited CAR T Cells for combinational therapy against T cell malignancies

2020-07-30

Abstract excerpt

Targeting T cell malignancies using chimeric antigen receptor (CAR) T cells is hindered by ‘T v T’ fratricide against shared antigens such as CD3 and CD7. Genome-editing can overcome such hurdles through targeted disruption of problematic shared antigens. Base editing offers the possibility of seamless disruption of gene expression through the creation of stop codons or elimination of splice donor or acceptor site...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9b7223ed-aca4-5cc8-a3c9-4d45116d8b8b
DOI
10.1101/2020.07.30.228429
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Base-edited CAR T Cells for combinational therapy against T cell malignanciesDOI 10.1101/2020.07.30.228429
Select a neighboring publication to make it the new centre.